SCHEMBL22858079

SCHEMBL22858079

CC(C)c1cc2c3ccccc3n3c4ccc5ccccc5c4c(c1)c23

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.33
RORA P35398 1/20 0.32
RORC P51449 1/20 0.32
RORB Q92753 1/20 0.32
UGT2B7 P16662 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
RAB9A P51151 1/20 0.32
CASP7 P55210 1/20 0.32
ATM Q13315 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HTR2A P28223 2/20 0.31
HTR2C P28335 1/20 0.31
BACE1 P56817 5/20 0.31
PTGES O14684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21710478 0.89 PTGES (0.34) AKR1B1UGT2B7HPGDRAB9AL3MBTL1
SCHEMBL17694640 0.85 GPR3 (0.40) RORARORCRORBHPGDATM
SCHEMBL21718096 0.85 RORA (0.39) AKR1B1RORARORCRORBUGT2B7
SCHEMBL21718131 0.84 CYP2A6 (0.40) CYP3A4HPGDTSHRMAPK1CASP1
SCHEMBL21717864 0.81 UGT2B7 (0.34) RORARORCRORBUGT2B7HPGD
SCHEMBL22858128 0.81 RORA (0.37) AKR1B1RORARORCRORBUGT2B7
SCHEMBL21710476 0.81 MAPT (0.47) HPGDHSD17B10L3MBTL1
SCHEMBL21718130 0.81 PTGES (0.33) CYP3A4HPGDTSHRMAPK1CASP1
SCHEMBL21710705 0.80 PTGES (0.36) HPGDTSHRHIF1AHSD17B10PTGES
SCHEMBL21710707 0.80 ATM (0.41) CYP3A4HPGDTSHRMAPK1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 AKR1B1 2345/4885RORA 924/4885RORC 1215/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 AKR1B1 3036/4885RORA 1163/4885RORC 1558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.